Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden

Skin Scarring Clinical Trial

Official title:
Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden

Status Withdrawn

Clinical Trial Summary

This is a prospective, randomized pilot study of patients who will undergo either early or late incisional laser therapy after breast reduction surgery to alleviate scar burden at NYU Langone Medical Center. The purpose of this study is to see how well carbon dioxide (CO2) laser therapy works at preventing scar formation after surgery.CO2 laser therapy is currently being used by dermatologists and plastic surgeons to help with scarring after acne and to rejuvenate the face; its benefits are now being explored by medical professionals in dermatology and cosmetic surgery to prevent scarring after surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03306628
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Withdrawn
Phase	N/A
Start date	November 15, 2017
Completion date	August 26, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03649308` - Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting	N/A
Recruiting	`NCT05618912` - Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment	N/A
Completed	`NCT03795116` - Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention	Phase 2
Active, not recruiting	`NCT01688063` - Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type
Completed	`NCT05704114` - Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne	Phase 4
Active, not recruiting	`NCT04915391` - Restenosis in Coronary Stents And Cutaneous HEaLing